Wiszniewski, Wojciech
Gawlinski, Pawel
Gambin, Tomasz
Bekiesinska-Figatowska, Monika
Obersztyn, Ewa
Antczak-Marach, Dorota
Akdemir, Zeynep Hande Coban
Harel, Tamar
Karaca, Ender
Jurek, Marta
Sobecka, Katarzyna http://orcid.org/0000-0002-9867-063X
Nowakowska, Beata
Kruk, Malgorzata
Terczynska, Iwona
Goszczanska-Ciuchta, Alicja
Rudzka-Dybala, Mariola
Jamroz, Ewa
Pyrkosz, Antoni
Jakubiuk-Tomaszuk, Anna
Iwanowski, Piotr
Gieruszczak-Bialek, Dorota
Piotrowicz, Malgorzata
Sasiadek, Maria
Kochanowska, Iwona
Gurda, Barbara
Steinborn, Barbara
Dawidziuk, Mateusz
Castaneda, Jennifer
Wlasienko, Pawel
Bezniakow, Natalia
Jhangiani, Shalini N.
Hoffman-Zacharska, Dorota
Bal, Jerzy
Szczepanik, Elzbieta
Boerwinkle, Eric
Gibbs, Richard A.
Lupski, James R.
Article History
Received: 10 April 2017
Revised: 28 February 2018
Accepted: 2 March 2018
First Online: 30 April 2018
Compliance with ethical standards
:
: J.R.L. has stock ownership in 23andMe and Lasergen and is a paid consultant for Regeneron. J.R.L. is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from the chromosomal microarray analysis (CMA) and clinical exome sequencing offered at Baylor Genetics (MGL;ExternalRef removed). The authors declare that they have no conflict of interest.